Monocytes - Health Rising

The Eternal ME/CFS Fibromyalgia Question: How Close Are They? And Why it Matters

by Cort Johnson | Oct 4, 2026 | Autonomic Nervous System, Brain, Cardiovascular, Clotting, Endothelial Cells, Energy Production, Fibromyalgia and Pain, Gut, Homepage, Immune, Inflammation, Leaky gut, Metabolism, Microbiome, Monocytes, Natural Killer Cells, Neuroinflammation, Neuroinflammation, Oxidative Stress, T-cells

Geoff’s Narration The GIST So much for the ME/CFS community depends on the answer to the question: “How close a match is ME/CFS to long COVID?” Symptomatically and physiologically, the two diseases look quite similar. If ME/CFS or other...

Exercise is Not Producing Muscle Damage in ME/CFS…It’s All About Muscle Repair

by Cort Johnson | Dec 21, 2025 | Clotting, Energy Production, Exercise, Homepage, Inflammation, Metabolism, Monocytes, Muscles, Neutrophils, Oxidative Stress, Research, T-cells

Exercise is not causing muscle damage in ME/CFS. Instead, inflammation, and problems with metabolism and poor muscle repair is producing postexertional malaise.

Long COVID – the Inflamed and Exhausted Disease? Plus, the JAK Drug Trial Boom

by Cort Johnson | Dec 17, 2025 | Complement, COVID-19, Cytokines, Drugs, Homepage, Immune, Inflammation, Interferons, JAK_STAT Inhibitors, Metabolism, Monocytes, Natural Killer Cells, Oxidative Stress, Pathogens, Research, T-cells, Treatment

Harvard researchers find an activated and exhausted immune system in long COVID patients - and begin a drug trial to try to fix it.

PrecisionLife’s Bold Attempt to Break the Code on and Beat ME/CFS and Long COVID

by Cort Johnson | Oct 27, 2025 | Artificial Intelligence, COVID-19, Energy Production, Genetics, GWAS (Genome-Wide Association Study), Homepage, Low Dose Naltrexone, Metabolism, Monocytes, Oxidative Stress, Pathogens, Research, T-cells

Geoff’s Narration The GIST This is the next in a series of blogs exploring ongoing projects in ME/CFS, FM and long COVID. The first featured the RECOVER project’s next set of long COVID clinical trials. RECOVER’s 2nd Round of Long COVID...